Oct 15, 2026, 7:00 AM EDT · 8 days ago ADMA Biologics Announces Peer-Reviewed Publication Highlighting New Data From Its Optimized, Proprietary IVIG Manufacturing Process
Sep 14, 2026, 9:21 AM EDT · 5 weeks ago Berger Montague PC Investigates ADMA Biologics, Inc.'s Board of Directors for Breach of Fiduciary Duty (ADMA)
Sep 8, 2026, 9:09 AM EDT · 6 weeks ago Berger Montague PC Investigates ADMA Biologics, Inc.'s Board of Directors for Breach of Fiduciary Duty (NASDAQ: ADMA)
2026-08-05T21:01:11.000Z · 2 months ago Adma Biologics backs FY26 revenue view $530M-$560M, consensus $534.37M
Aug 5, 2026, 4:05 PM EDT · 2 months ago ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update
Jul 31, 2026, 1:20 PM EDT · 2 months ago ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.
Jul 30, 2026, 10:07 AM EDT · 2 months ago SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 10, 2026 in ADMA BIOLOGICS, INC. Lawsuit - ADMA
Jul 29, 2026, 7:00 AM EDT · 2 months ago ADMA Biologics to Report Second Quarter 2026 Financial Results on August 5, 2026
Jul 27, 2026, 10:00 AM EDT · 2 months ago Did You Lose Money Investing in ADMA Biologics, Inc. (ADMA)? Contact Robbins LLP for Information About Recovering Your Losses
Jul 24, 2026, 6:34 AM EDT · 3 months ago $ADMA Fraud Notification: ADMA Biologics Sued for Fraud Over Misrepresentations about Channel Stuffing – Investors Notified to Contact BFA Law
2026-07-15T11:25:44.000Z · 3 months ago Adma Biologics price target lowered to $17 from $20 at Mizuho
Jul 6, 2026, 6:48 AM EDT · 3 months ago $ADMA Fraud Notification: ADMA Biologics Sued for Securities Fraud After Channel Stuffing Claims Spark a 29% Stock Drop – Investors Notified to Contact BFA Law by August 10
Jul 2, 2026, 7:00 PM EDT · 3 months ago ADMA INVESTOR REMINDER: ADMA Biologics, Inc. Investors Have Until August 10, 2026 To Seek Lead Plaintiff Role
Jun 24, 2026, 9:24 AM EDT · 4 months ago ADMA BIOLOGICS, INC. (ADMA) INVESTOR ALERT Investors With Large Losses in ADMA Biologics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
Jun 23, 2026, 7:55 AM EDT · 4 months ago Grabar Law Office Investigates ADMA Biologics, Inc. (ADMA) on Behalf of Long-Term Shareholders
Jun 15, 2026, 10:53 AM EDT · 4 months ago 20 growth stocks priced as value stocks AMG ANIP ARR BILL CG DAN EFC
Jun 11, 2026, 1:33 PM EDT · 4 months ago $ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop – Investors Notified to Contact BFA Law
Jun 10, 2026, 6:41 AM EDT · 4 months ago ADMA Biologics Investigation: ADMA Biologics (ADMA) Investigated for Alleged Channel Stuffing – Contact BFA Law if You Suffered Losses
Jun 3, 2026, 6:07 AM EDT · 4 months ago ADMA Legal Claims: ADMA Biologics may have Misrepresented its Revenue Sources to Investors – Contact BFA Law about its Pending Securities Fraud Investigation
May 29, 2026, 6:33 AM EDT · 4 months ago $ADMA Securities News: ADMA Biologics Investigated for Securities Fraud Over Channel Stuffing Allegations – Investors with Losses Notified to Contact BFA Law
May 25, 2026, 7:18 AM EDT · 5 months ago $ADMA Shareholder Announcement: ADMA Biologics may have Misled Investors about its Revenue – Contact BFA Law about its Pending Investigation
May 22, 2026, 6:43 AM EDT · 5 months ago ADMA Inquiry News: ADMA Biologics Investors are Notified of BFA Law's Ongoing Investigation into the Company's Potential Misstatements – Contact the Firm if You Lost Money
May 20, 2026, 6:20 AM EDT · 5 months ago ADMA Securities Investigation: ADMA Biologics 29% Stock Drop Triggers Securities Fraud Investigation Over Channel Stuffing Claims – Investors Urged to Contact BFA Law
May 18, 2026, 6:07 AM EDT · 5 months ago ADMA Fraud Notice: ADMA Biologics is being Investigated for Securities Fraud after 29% Stock Drop -- Investors Reminded to Contact BFA Law
May 15, 2026, 6:33 AM EDT · 5 months ago ADMA Shareholder News: ADMA Biologics Investigated for Securities Fraud Over Alleged Misrepresentations about Channel Stuffing – Investors Notified to Contact BFA Law
May 11, 2026, 6:15 AM EDT · 5 months ago $ADMA Investigation Reminder: ADMA Biologics Investigation on behalf of Investors is Ongoing – Contact BFA Law if You Lost Money
May 8, 2026, 6:07 AM EDT · 5 months ago $ADMA Investor News: ADMA Biologics Stock Drops 29% Amid Channel Stuffing Claims Triggering Securities Fraud Investigation – Contact BFA Law if You Suffered Losses
2026-05-07T16:02:55.000Z · 5 months ago Adma Biologics price target lowered to $20 from $24 at Mizuho
May 7, 2026, 9:16 AM EDT · 5 months ago ADMA Biologics Stock Alert (ADMA) - Kehoe Law Firm, P.C. Investigating Potential Securities Claims on Behalf of ADMA Biologics Investors
2026-05-07T10:48:12.000Z · 5 months ago Adma Biologics price target lowered to $18 from $21 at Canaccord
2026-05-07T00:36:02.000Z · 5 months ago Adma Biologics sees FY26 revenue $530M-$560M, consensus $629.1M
May 6, 2026, 4:05 PM EDT · 5 months ago ADMA Biologics Reports First Quarter 2026 Financial Results and Provides Business Update
May 6, 2026, 6:41 AM EDT · 5 months ago $ADMA Shareholder News: ADMA Biologics 29% Stock Drop Leads to Securities Fraud Investigation – BFA Law Encourages Investors with Losses to Act
May 4, 2026, 7:00 AM EDT · 5 months ago ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older
May 1, 2026, 6:16 AM EDT · 5 months ago Investor Notice: ADMA Biologics (NASDAQ:ADMA) may have Committed Securities Fraud after Channel Stuffing Claims Disclosed – Contact BFA Law about the Pending Investigation
Apr 29, 2026, 7:00 AM EDT · 5 months ago ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026
2026-04-13T14:43:12.000Z · 6 months ago Adma Biologics price target lowered to $24 from $30 at Mizuho
2026-03-27T11:42:03.000Z · 7 months ago Adma Biologics responds to short seller report by Culper Research
2026-03-26T08:50:09.000Z · 7 months ago Cantor downgrades Adma Biologics on lack of clarity post short report
2026-03-25T23:25:28.000Z · 7 months ago Adma Biologics says Culper report contains ‘inaccurate statements’